CASE 04
POM Wonderful: Crazy Healthy!
CASE NOTES FOR INSTRUCTORS
This case introduces students to the company POM Wonderful. Most likely these students are
already familiar with the company’s renowned hour-glass shaped bottles of pomegranate juice.
POM Wonderful has a good reputation because of the pomegranate products it sells. Pomegranates
are high in antioxidants and are thought to be helpful in combating some diseases. This case is
unique because despite POM Wonderful’s reputation as a company that sells healthy products, the
Federal Trade Commission ruled that its advertising was deceptive. This demonstrates that even
companies that sell products beneficial to society must still be careful about how they advertise
their products.
POM Wonderful has secured a large portion of the pomegranate beverage market. Like most firms,
it takes great strides to protect its market share. For instance, POM Wonderful filed a lawsuit against
Coca-Cola after it introduced its Minute Maid pomegranate-blueberry juice blend because the
beverage consisted mostly of apple and grape juices, not pomegranates. However, POM Wonderful
would face its own legal scrutiny in 2010 when the Food and Drug Administration sent POM
Wonderful a letter claiming that its products were being marketed similarly to pharmaceuticals in
terms of their touted health benefits. For instance, company ads claim that pomegranates can help
prevent certain diseases or maladies, such as erectile dysfunction and prostate cancer, as well as
have a positive impact on LDL cholesterol. As such, POM Wonderful was required to prove with
scientific rigor that its juice products were beneficial in the curing, mitigation, treatment, and/or
prevention of diseases. Because POM Wonderful’s claims were not substantiated, its ads were
deceptive.
The Federal Trade Commission (FTC) found POM Wonderful guilty of violating the Federal Trade
Commission Act. It ruled that POM Wonderful had made unsubstantiated efficacy and establishment
claims. It forbade POM Wonderful from making any more health claims unless they were
substantiated by two randomized and controlled human clinical trials.
POM Wonderful appealed the ruling, but the U.S. Court of Appeals upheld most of the FTC’s ruling. It
did say, however, that two human trials were excessive and that one clinical trial would be enough to
provide valuable health information.
What is so interesting is that unlike new and untested pharmaceuticals, pomegranates almost
certainly have health benefits of some sort. They do not have nearly the same risks as untested
pharmaceuticals. Therefore, it could be argued that POM Wonderful’s beverages are being held to
unrealistic standards. The U.S. Court of Appeals seemed to agree as it ruled that POM Wonderful
only had to perform one clinical trial. This case could be used as a debate exercise for whether food
should be held to the same standards as pharmaceuticals regarding the promotion of health
benefits.
© 2019 Cengage Learning. All rights reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license
distributed with a certain product or service or otherwise on a password-protected website for classroom use.